Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 2 boards, counting each seat separately. Longest: Rocket Pharmaceuticals Inc., 3 years.
Rocket Pharmaceuticals Inc.
Director
Atrium Therapeutics Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Rocket Pharmaceuticals Inc. May 20, 202699.1%
-
Rocket Pharmaceuticals Inc. June 18, 202598.8%
-
Rocket Pharmaceuticals Inc. June 13, 202499.2%
-
Rocket Pharmaceuticals Inc. June 22, 202398.0%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 18, 2026 | Rocket Pharmaceuticals Inc. | Grant or award | +22,862 | — | — |
| Jun 18, 2025 | Rocket Pharmaceuticals Inc. | Grant or award | +30,000 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.